Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masaki Ri

Showing results (1-10 of 116) with videos related to

Pageof 12
Sort By:
International Journal of Hematology|May 13, 2016
Endoplasmic-reticulum stress pathway-associated mechanisms of action of proteasome inhibitors in multiple myelomaMasaki Ri
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 3, 2024
[Novel therapies for multiple myeloma]Masaki Ri
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 10, 2023
[CAR-T therapy for multiple myeloma]Masaki Ri
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 8, 2026
[Current state and key challenges of immune and cell therapy for multiple myeloma in Japan]Masaki Ri
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 12, 2018
[Role of novel proteasome inhibitors in the treatment of relapsed/refractory multiple myeloma]Masaki Ri
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 7, 2016
Mechanism of action and determinants of sensitivity to the proteasome inhibitor bortezomib in multiple myeloma therapyMasaki Ri
Ejhaem|January 16, 2026
Whole Genome and Single-Cell RNA Sequencing Reveals Clonal Evolution and Heterogeneity of Secondary Plasma Cell Leukemia: A Case ReportTomotaka Suzuki, Rui Yokomori, Takaomi Sanda, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 2, 2006
[Histopathological findings of pulmonary complications in 16 patients who received allogeneic hematopoietic stem cell transplants]Hiroatsu Iida, Masaki Ri, Keiko Niimi, et al.
Organic Letters|April 29, 2016
Design, Synthesis, and Biological Activity of Isosyringolin AShun Kitahata, Takuya Chiba, Takashi Yoshida, et al.
Cancer Science|June 21, 2019
Immunohistochemistry for identification of CCND1, NSD2, and MAF gene rearrangements in plasma cell myelomaTakayuki Murase, Masaki Ri, Tomoko Narita, et al.
Pageof 12

Showing results (1-10 of 116) with videos related to

Sort By:
Pageof 12
International Journal of Hematology|May 13, 2016
Endoplasmic-reticulum stress pathway-associated mechanisms of action of proteasome inhibitors in multiple myelomaMasaki Ri
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 3, 2024
[Novel therapies for multiple myeloma]Masaki Ri
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 10, 2023
[CAR-T therapy for multiple myeloma]Masaki Ri
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 8, 2026
[Current state and key challenges of immune and cell therapy for multiple myeloma in Japan]Masaki Ri
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 12, 2018
[Role of novel proteasome inhibitors in the treatment of relapsed/refractory multiple myeloma]Masaki Ri
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 7, 2016
Mechanism of action and determinants of sensitivity to the proteasome inhibitor bortezomib in multiple myeloma therapyMasaki Ri
Ejhaem|January 16, 2026
Whole Genome and Single-Cell RNA Sequencing Reveals Clonal Evolution and Heterogeneity of Secondary Plasma Cell Leukemia: A Case ReportTomotaka Suzuki, Rui Yokomori, Takaomi Sanda, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 2, 2006
[Histopathological findings of pulmonary complications in 16 patients who received allogeneic hematopoietic stem cell transplants]Hiroatsu Iida, Masaki Ri, Keiko Niimi, et al.
Organic Letters|April 29, 2016
Design, Synthesis, and Biological Activity of Isosyringolin AShun Kitahata, Takuya Chiba, Takashi Yoshida, et al.
Cancer Science|June 21, 2019
Immunohistochemistry for identification of CCND1, NSD2, and MAF gene rearrangements in plasma cell myelomaTakayuki Murase, Masaki Ri, Tomoko Narita, et al.
Pageof 12